Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Sarris

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Oncology (Williston Park, N.Y.)|August 30, 2002
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trialA H Sarris, A Phan, A Goy, et al.
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Leukemia & Lymphoma|May 9, 2001
Infusional vinorelbine in relapsed or refractory lymphomasA H Sarris, A Psyrri, F Hagemeister, et al.
Blood|April 27, 1999
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphomaA López-Guillermo, F Cabanillas, T I McDonnell, et al.
Haematologica|March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphomaT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survivalA H Sarris, K O Kliche, P Pethambaram, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimensT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Annals of Internal Medicine|July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trialG Steinbach, R Ford, G Glober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study GroupE Zucca, A Conconi, T I Mughal, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Oncology (Williston Park, N.Y.)|August 30, 2002
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trialA H Sarris, A Phan, A Goy, et al.
Seminars in Oncology|February 28, 2001
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphomaP McLaughlin, F B Hagemeister, M A Rodriguez, et al.
Leukemia & Lymphoma|May 9, 2001
Infusional vinorelbine in relapsed or refractory lymphomasA H Sarris, A Psyrri, F Hagemeister, et al.
Blood|April 27, 1999
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphomaA López-Guillermo, F Cabanillas, T I McDonnell, et al.
Haematologica|March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphomaT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survivalA H Sarris, K O Kliche, P Pethambaram, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimensT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Annals of Internal Medicine|July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trialG Steinbach, R Ford, G Glober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study GroupE Zucca, A Conconi, T I Mughal, et al.
Pageof 6